Advances in Immunotherapy for the Treatment of Adult Glioblastoma: Overcoming Chemical and Physical Barriers

SIMPLE SUMMARY: The poor prognosis for glioblastoma (GBM) despite the existence of a standard-of-care treatment of resection, radiotherapy, and adjuvant chemotherapy has necessitated the exploration of other therapeutic avenues. One particularly promising avenue is an immunotherapeutic approach in w...

Descripción completa

Detalles Bibliográficos
Autores principales: Lechpammer, Mirna, Rao, Rohan, Shah, Sanjit, Mirheydari, Mona, Bhattacharya, Debanjan, Koehler, Abigail, Toukam, Donatien Kamdem, Haworth, Kevin J., Pomeranz Krummel, Daniel, Sengupta, Soma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997081/
https://www.ncbi.nlm.nih.gov/pubmed/35406398
http://dx.doi.org/10.3390/cancers14071627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997081/
https://www.ncbi.nlm.nih.gov/pubmed/35406398
http://dx.doi.org/10.3390/cancers14071627

Ejemplares similares